1 Vuoriluoto K, "Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer" 30 : 1436-1448, 2011
2 Baumann C, "Torka GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance" 11 : 1430-1447, 2017
3 Creighton CJ, "The role of epithelial-mesenchymal transition programming in invasion and metastasis : a clinical perspective" 5 : 187-195, 2013
4 Liu GW, "The reversal effect of ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism" 31 : 189-198, 2018
5 Uribe DJ, "The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer" 12 : e0179979-, 2017
6 Goyette MA, "The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression" 23 : 1476-1490, 2018
7 Rankin EB, "The receptor tyrosine kinase AXL in cancer progression" 8 : 103-, 2016
8 Li J, "The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma" 111 : 3222-3235, 2020
9 Akbari Dilmaghani N, "The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma : possibilities for therapeutic interventions either as single agents or in combination with conventional therapies" 73 : 618-642, 2021
10 Melaragno MG, "The Gas6/Axl system : a novel regulator of vascular cell function" 9 : 250-253, 1999
1 Vuoriluoto K, "Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer" 30 : 1436-1448, 2011
2 Baumann C, "Torka GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance" 11 : 1430-1447, 2017
3 Creighton CJ, "The role of epithelial-mesenchymal transition programming in invasion and metastasis : a clinical perspective" 5 : 187-195, 2013
4 Liu GW, "The reversal effect of ginsenoside Rh2 on drug resistance in human colorectal carcinoma cells and its mechanism" 31 : 189-198, 2018
5 Uribe DJ, "The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer" 12 : e0179979-, 2017
6 Goyette MA, "The receptor tyrosine kinase AXL is required at multiple steps of the metastatic cascade during HER2-positive breast cancer progression" 23 : 1476-1490, 2018
7 Rankin EB, "The receptor tyrosine kinase AXL in cancer progression" 8 : 103-, 2016
8 Li J, "The crosstalk between AXL and YAP promotes tumor progression through STAT3 activation in head and neck squamous cell carcinoma" 111 : 3222-3235, 2020
9 Akbari Dilmaghani N, "The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma : possibilities for therapeutic interventions either as single agents or in combination with conventional therapies" 73 : 618-642, 2021
10 Melaragno MG, "The Gas6/Axl system : a novel regulator of vascular cell function" 9 : 250-253, 1999
11 Nunnery SE, "Targeting the PI3K/AKT/mTOR pathway in hormonepositive breast cancer" 80 : 1685-1697, 2020
12 Liu X, "Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo" 145 : 1007-1019, 2019
13 Lei J, "Src kinase integrates PI3K/Akt and MAPK/ERK1/2 pathways in T3-induced Na-K-ATPase activity in adult rat alveolar cells" 301 : L765-L771, 2011
14 Ludwig KF, "Small-molecule inhibition of Axl targets tumor immune suppression and enhances chemotherapy in pancreatic cancer" 78 : 246-255, 2018
15 Ma J, "Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism" 18 : 630-636, 2019
16 De Craene B, "Regulatory networks defining EMT during cancer initiation and progression" 13 : 97-110, 2013
17 Kong L, "Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelialmesenchymal transition" 12 : 9714-9725, 2020
18 Liu H, "PTP1B promotes cell proliferation and metastasis through activating src and ERK1/2 in non-small cell lung cancer" 359 : 218-225, 2015
19 Miricescu D, "PI3K/AKT/mTOR signaling pathway in breast cancer : from molecular landscape to clinical aspects" 22 : 173-, 2020
20 Okura N, "ONO-7475, a novel AXL inhibitor, suppresses the adaptive resistance to initial EGFR-TKI treatment in EGFR-mutated non-small lung cancer" 26 : 2244-2256, 2020
21 Li Y, "Natural compound oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways" 9 : 538-, 2018
22 Krishnamoorthy GP, "Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin(17-AAG)-induced AXL receptor tyrosine kinase degradation" 288 : 17481-17494, 2013
23 Han Y, "MLH1deficiency induces cetuximab resistance in colon cancer via Her-2/PI3K/AKT signaling" 7 : 2000112-, 2020
24 Chang F, "Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation : a target for cancer chemotherapy" 17 : 590-603, 2003
25 Bae CA, "Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma" 23 : 824-836, 2020
26 Tong-Lin Wu T, "Induction of apoptosis in prostate cancer by ginsenoside Rh2" 9 : 11109-11118, 2018
27 Song X, "Hematopoietic progenitor kinase 1 downregulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer" 295 : 2348-2358, 2020
28 Kim HIe, "Growth-stimulatory activity of TIMP-2 is mediated through c-Src activation followed by activation of FAK, PI3-kinase/AKT, and ERK1/2 independent of MMP inhibition in lung adenocarcinoma cells" 6 : 42905-42922, 2015
29 Jianjun Yang ; Donghong Yuan ; Tongchao Xing ; Hongli Su ; Shengjun Zhang ; Jiansheng Wen ; Qiqiang Bai ; Dongmei Dang, "Ginsenoside Rh2 inhibiting HCT116 colon cancer cell proliferation through blocking PDZ-binding kinase/T-LAK cell-originated protein kinase" 고려인삼학회 40 (40): 400-408, 2016
30 Ge G, "Ginsenoside Rh2 inhibited proliferation by inducing ROS Mediated ER stress dependent apoptosis in Lung cancer cells" 40 : 2117-2124, 2017
31 Li B, "Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53" 301 : 185-192, 2011
32 Li C, "Ginsenoside Rh2 impedes proliferation and migration and induces apoptosis by regulating NF-kappaB, MAPK, and PI3K/Akt/mTOR signaling pathways in osteosarcoma cells" 34 : e22597-, 2020
33 Hyunkyung Lee ; Seungyeon Lee ; Dawoon Jeong ; Sun Jung Kim, "Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells" 고려인삼학회 42 (42): 455-462, 2018
34 Lv DL, "Ginsenoside GRh2synergizes with SMI-4a in anti-melanoma activity through autophagic cell death" 13 : 11-, 2018
35 Shi X, "Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through the Akt/GSK3beta signaling pathway in human cervical cancer cells" 17 : 4811-4816, 2018
36 Lü JM, "Ginseng compounds : an update on their molecular mechanisms and medical applications" 7 : 293-302, 2009
37 Yan HZ, "GHR is involved in gastric cell growth and apoptosis via PI3K/AKT signalling" 25 : 2450-2458, 2021
38 Zhang G, "Function of Axl receptor tyrosine kinase in non-small cell lung cancer" 15 : 2726-2734, 2018
39 Song RX, "Estrogen rapid action via protein complex formation involving ERalpha and Src" 16 : 347-353, 2005
40 Yeung KT, "Epithelial-mesenchymal transition in tumor metastasis" 11 : 28-39, 2017
41 Koopman LA, "Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer" 4 : e128199-, 2019
42 Hong P, "Echinatin suppresses esophageal cancer tumor growth and invasion through inducing AKT/mTOR-dependent autophagy and apoptosis" 11 : 524-, 2020
43 Siegel RL, "Colorectal cancer statistics, 2020" 70 : 145-164, 2020
44 Li Y, "Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma" 66 : 507-518, 2014
45 Tian Y, "Anexelekto(AXL)increases resistance to EGFR-TKI and activation of AKT and ERK1/2 in non-small cell lung cancer cells" 24 : 295-303, 2016
46 Moghimi-Dehkordi B, "An overview of colorectal cancer survival rates and prognosis in Asia" 4 : 71-75, 2012
47 Zhao R, "Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase" 177 : 2303-2319, 2020
48 Terry S, "AXL targeting overcomes human lung cancer cell resistance to NK-and CTL-mediated cytotoxicity" 7 : 1789-1802, 2019
49 Lotsberg ML, "AXL targeting abrogates autophagic flux and induces immunogenic cell death in drug-resistant cancer cells" 15 : 973-999, 2020
50 Zhu C, "AXL receptor tyrosine kinase as a promising anti-cancer approach : functions, molecular mechanisms and clinical applications" 18 : 153-, 2019
51 Divine LM, "AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer" 7 : 77291-77305, 2016
52 Axelrod HD, "AXL is a putative tumor suppressor and dormancy regulator in prostate cancer" 17 : 356-369, 2019
53 Cardone C, "AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer" 138 : 1-10, 2020
54 Collina F, "AXL is a novel predictive factor and therapeutic target for radioactive iodine refractory thyroid cancer" 11 : 785-, 2019
55 Dunne PD, "AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer" 20 : 164-175, 2014
56 Kim D, "AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells" 10 : 361-, 2019
57 Zajac O, "AXL controls directed migration of mesenchymal triple-negative breast cancer cells" 9 : 247-, 2020
58 Abu-Thuraia A, "AXL confers cell migration and invasion by hijacking a PEAK1-regulated focal adhesion protein network" 11 : 3586-, 2020
59 Zhou B, "A dynamic study on reversal of multidrug resistance by ginsenoside Rh(2)in adriamycinresistant human breast cancer MCF-7 cells" 88 : 345-351, 2012
60 Ting Xia ; Jin Zhang ; Chuanxin Zhou ; Yu Li ; Wenhui Duan ; Bo Zhang ; Min Wang ; Jianpei Fang, "20(S)-Ginsenoside Rh2 displays effi cacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway" 고려인삼학회 44 (44): 725-737, 2020